TCL Archive In Brief: Special Meeting To Review Viral Oncology Asked by DCCP Board; BCTF Budget: $8 Million October 31, 1980
TCL Archive UK’s NICE Set to Deny Payments For Zaltrap In Second-Line Metastatic Colorectal Cancer June 26, 2013
TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
